Avacta Life Sciences Limited
  • About
  • Therapeutics
  • Diagnostics
    • Diagnostics
    • Products
    • Affimer®
    • Key benefits
    • Partnering
    • Resources
    • News
  • Investors
  • News
  • Careers
  • Contact
  • About
    • About Avacta
    • People
    • Scientific Resources
    • Intellectual Property
    • Virtual tour
  • Therapeutics
    • Therapeutics
    • Affimer®
    • preCISIONTM
    • Pipeline
    • Partnering
    • Clinical trials
    • News
  • Diagnostics
    • Diagnostics
    • Products
    • Affimer®
    • Key benefits
    • Partnering
    • Resources
    • News
  • Investors
    • Investors
    • CEO Welcome
    • Key information
    • Corporate Governance
    • Documents & Presentations
    • Share price
    • RNS News
  • News
  • Careers
    • CEO Welcome
    • Job vacancies
    • About Avacta
    • Benefits of working at Avacta
  • Contact
  • About
    • About Avacta
    • People
    • Scientific Resources
    • Intellectual Property
    • Virtual tour
  • Therapeutics
    • Therapeutics
    • Affimer®
    • preCISIONTM
    • Pipeline
    • Partnering
    • Clinical trials
    • News
  • Diagnostics
    • Diagnostics
    • Products
    • Affimer®
    • Key benefits
    • Partnering
    • Resources
    • News
  • Investors
    • Investors
    • CEO Welcome
    • Key information
    • Corporate Governance
    • Documents & Presentations
    • Share price
    • RNS News
  • News
  • Careers
    • CEO Welcome
    • Job vacancies
    • About Avacta
    • Benefits of working at Avacta
  • Contact
Home News Diagnostics Page 4
filter by: view all | Blogs | Diagnostics | Investors | Therapeutics

Diagnostics

07 Sep 2020

Avacta to Launch SARS-CoV-2 ELISA Laboratory Test

Diagnostics | Investors
02 Sep 2020

Avacta Expands Rapid SARS-CoV-2 Antigen Test Manufacturing Capacity

Diagnostics | Investors
07 Aug 2020

SARS-CoV-2 Rapid Antigen Test Clinical Collaboration

Diagnostics | Investors
06 Aug 2020

COVID-19 Rapid Antigen Test Manufacturing Partner

Diagnostics | Investors
22 Jul 2020

Update on Clinical Validation of Adeptrix COVID-19 Diagnostic Test

Diagnostics | Investors
13 Jul 2020

Collaboration with Integumen plc for Detection of SARS-COV-2 Coronavirus in Waste Water

Diagnostics | Investors
26 Jun 2020

Interview with Alastair Smith on Cytiva update

Diagnostics | Investors
25 Jun 2020

Responding to disease outbreaks – the importance of point-of-care diagnostics

Blogs | Diagnostics
24 Jun 2020

Update on COVID-19 Rapid Antigen Test Development Partnership with Cytiva

Diagnostics | Investors
23 Jun 2020

How diagnostic test performance is measured

Diagnostics | Investors

Posts navigation

Older posts
Newer posts
Avacta Life Sciences Limited
  • Terms of Use
  • Terms & Conditions
  • Privacy Policy
  • Intellectual Property
  • Returns & cancellations policy
  • Corporate Responsibility
  • Contact Us

Avacta Diagnostics

Unit 20, Ash Way
Thorp Arch Estate
Wetherby
LS23 7FA
+44 (0)1904 21 7070

virtual tour
email

Avacta Therapeutics

Scale Space,  White City
Imperial College Campus
58 Wood Lane
London
W12 7RZ

+44 (0)20 3871 9700

Investor Enquiries

FTI Consulting
200 Aldersgate
Aldersgate Street
London
EC1A 4HD

Email

Twitter | Linkedin

©2023 Avacta Life Sciences Limited. Registered company no. 06605196.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok